Exosome Industry Biotech Report 2022

Exosome Industry Biotech Report 2022

Summary

In this report, we describe 45 companies (see below) that have emerged over the last decade to pursue exosome therapeutics and diagnostic goals. Two tables provide a quick reference with information on investor funding and founding date. A further table provides a summary of 242 exosome-focused clinical trials.

Download the report 

Exosome Therapeutic and Diagnostic Companies Covered

Therapeutics

Diagnostics

Adipomics

Biological Dynamics

Aegle Therapeutics

ExosomeDx

Aethlon Medical

Exosome Plus

Anjarium Biosciences

Exosome Sciences

Aruna Bio

Exosomics

Avalon Globocare

NanoSomix

BrainStorm Cell Therapeutics

Nanostics

Capricor Therapeutics

Oasis Diagnostics

Carmine Therapeutics

Sienna Diagnostics

Ciloa

Theoria Science

Codiak BioSciences

 

Creative Medical Technology

 

Direct Biologics

 

 

Divide and Conquer

 

 

Evox Therapeutics

 

 

ExoCoBio

 

   

Exopharm

 

 

Ilias Biologics

 

 

Innocan Pharma

 

 

Kimera Labs

 

 

MantraBio

 

 

MDimune

 

 

Neurexo Sciences

 

 

OmniSpirant

 

 

Organicell

 

 

Puretech Health

 

 

ReNeuron

 

 

Stem Cell Medicine, Ltd.

 

 

TAVEC Pharmaceuticals

 

 

The Cell-Factory

 

 

Unicyte

 

 

Versatope

 

 

Vesvigen Therapeutics

 

 

VivaZome Therapeutics

 

 

XOStem Inc.

 

 

  

Learn more about powerful technologies that are enabling research: